Amgen SVP has 93 shares withheld for taxes

Amgen Inc. senior vice president Rachna Khosla had 93 shares of common stock withheld on May 7, 2026 to cover tax obligations.

Rhea-AI Filing Summary

Amgen Inc. senior vice president Rachna Khosla had 93 shares of common stock withheld on May 7, 2026 to cover tax obligations. The shares were valued at $331.11 each. After this tax-withholding disposition, she directly holds 8,394 shares of Amgen common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 93 shares

Exercise Price or Tax Liability 1 txn

Insider Khosla Rachna

Role SVP, Business Development

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	93	$331.11	$31K

Holdings After Transaction: Common Stock — 8,394 shares (Direct)

Footnotes (1)

1. F1. These shares include 59 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Key Figures

Tax-withholding shares: 93 shares Tax-withholding price: $331.11 per share Shares held after transaction: 8,394 shares +2 more

5 metrics

Tax-withholding shares 93 shares Common stock disposed on May 7, 2026 for tax withholding

Tax-withholding price $331.11 per share Value used for the 93 shares delivered for taxes

Shares held after transaction 8,394 shares Direct Amgen common stock holdings after tax-withholding disposition

Tax-withholding transactions 1 transaction Form 4 summary shows one tax-withholding event (code F)

Tax-withholding share count summary 93 shares transactionSummary taxWithholdingShares

Key Terms

Dividend Equivalents, Restricted Stock Units, qualifying dividend reinvestment plan, Equity Incentive Plan

4 terms

Dividend Equivalents financial

"These shares include 59 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

Restricted Stock Units financial

"DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

qualifying dividend reinvestment plan financial

"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan"

Equity Incentive Plan financial

"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Amgen (AMGN) SVP Rachna Khosla report?

Amgen senior vice president Rachna Khosla reported a tax-withholding disposition of 93 shares of common stock. The transaction occurred on May 7, 2026, and reflects shares withheld to satisfy tax liabilities rather than an open-market sale of stock.

At what price were the 93 Amgen (AMGN) shares used for tax withholding?

The 93 Amgen shares used for tax withholding were valued at $331.11 per share. This valuation determines the amount applied toward the reporting person’s tax obligations related to equity compensation, instead of representing a discretionary buy or sell decision in the open market.

How many Amgen (AMGN) shares does Rachna Khosla hold after this Form 4 transaction?

Following the reported tax-withholding disposition, Rachna Khosla directly holds 8,394 shares of Amgen common stock. This remaining position shows she continues to maintain a meaningful equity stake in the company after the small number of shares used for tax purposes.

Is the Amgen (AMGN) Form 4 transaction an open-market sale of shares?

No, the Form 4 transaction is classified as a tax-withholding disposition, not an open-market sale. Code F indicates shares were delivered to cover exercise or tax liabilities related to equity awards, a routine administrative event rather than a discretionary trading decision.

What does the footnote about Dividend Equivalents mean in the Amgen (AMGN) filing?

The footnote explains that the reported holdings include 59 Dividend Equivalents granted under Amgen’s equity incentive plan. These are credited to unvested Restricted Stock Units and paid out in Amgen common shares on a one-to-one basis according to the vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 08:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Khosla Rachna

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Business Development

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2026		F		93	D	$331.11	8,394(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares include 59 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

	/s/ Rachna Khosla	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)